Coxib-inhibition of Duodenal Polyp Growth in FAP
收藏NIAID Data Ecosystem2026-03-06 收录
官方服务：
资源简介：
Preliminary data indicate a protective effect on the development of duodenal polyps by coxib treatment. The hypothesis of the present study is that normal therapy doses of rofecoxib for 1 year would stop or reverse the development of premalignant adenomatous lesions in the duodenal mucosa of FAP patients.
创建时间：
2003-09-15
